[HTML][HTML] Chlamydia trachomatis genital infections

CM O'Connell, ME Ferone - Microbial cell, 2016 - ncbi.nlm.nih.gov
Etiology, transmission and protection: Chlamydia trachomatis is the leading cause of
bacterial sexually transmitted infection (STI) globally. However, C. trachomatis also causes …

Pelvic Inflammatory Disease Due to Neisseria gonorrhoeae and Chlamydia trachomatis: Immune Evasion Mechanisms and Pathogenic Disease Pathways

T Darville - The Journal of infectious diseases, 2021 - academic.oup.com
Pelvic inflammatory disease (PID) results from ascension of sexually transmitted pathogens
from the lower genital tract to the uterus and/or fallopian tubes in women, with potential …

Immune signature of Chlamydia vaccine CTH522/CAF® 01 translates from mouse-to-human and induces durable protection in mice

AW Olsen, I Rosenkrands, CS Jacobsen… - Nature …, 2024 - nature.com
The clinical development of an effective Chlamydia vaccine requires in-depth understanding
of how well protective pre-clinical immune signatures translate to humans. Here, we report a …

Does male circumcision reduce women's risk of sexually transmitted infections, cervical cancer, and associated conditions?

BJ Morris, CA Hankins, J Banerjee… - Frontiers in public …, 2019 - frontiersin.org
Background: Male circumcision (MC) is proven to substantially reduce men's risk of a
number of sexually transmitted infections (STIs). We conducted a detailed systematic review …

Association between male circumcision and women's biomedical health outcomes: a systematic review

JM Grund, TS Bryant, I Jackson, K Curran… - The Lancet Global …, 2017 - thelancet.com
Background Male circumcision reduces men's risk of acquiring HIV and some sexually
transmitted infections from heterosexual exposure, and is essential for HIV prevention in sub …

Chlamydia trachomatis vaccines for genital infections: where are we and how far is there to go?

LM de la Maza, TL Darville, S Pal - Expert review of vaccines, 2021 - Taylor & Francis
Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. Antibiotic treatment does not prevent against reinfection and a …

Advances in vaccine development for Chlamydia trachomatis

TB Poston - Pathogens and Disease, 2024 - academic.oup.com
Chlamydia trachomatis is the most prevalent bacterial sexually transmitted infection globally.
Antibiotic treatment is highly effective, but infection is often asymptomatic resulting in most …

Status of vaccine research and development of vaccines for Chlamydia trachomatis infection

TB Poston, SL Gottlieb, T Darville - Vaccine, 2019 - Elsevier
Genital infection with Chlamydia trachomatis, a gram-negative obligate intracellular
bacterium, is the most common bacterial sexually transmitted infection globally. Ascension of …

Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives

J Deese, S Pradhan, H Goetz… - Open access journal of …, 2018 - Taylor & Francis
Purpose Evidence on the association between contraceptive use and risk of sexually
transmitted infections (STIs) and bacterial vaginosis (BV) is lacking, with few prospective …

Chlamydia trachomatis vaccine development – a view on the current challenges and how to move forward

ÁH Borges, F Follmann, J Dietrich - Expert Review of Vaccines, 2022 - Taylor & Francis
Introduction Chlamydia trachomatis is the most common sexually transmitted bacterial
pathogen in the world. A licensed vaccine is not yet available, but the first vaccines have …